MONOZECLAR Side Effects

6757982-2 | Back Pain, Dyspepsia, Fatigue, Pruritus, Purpura, Vasculitis
on May 28, 2010 Female patient from FRANCE , 44 years of age, was diagnosed with sinusitis (What is sinusitis?) and was treated with Monozeclar (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), dyspepsia, fatigue, pruritus, purpura, vasculitis (What is vasculitis?). Monozeclar dosage: .

6747671-2 | Back Pain, Dyspepsia, Fatigue, Pruritus, Purpura, Vasculitis
Patient was taking Monozeclar (View Usage). Patient had the following side effects: back pain (What is back pain?), dyspepsia, fatigue, pruritus, purpura, vasculitis (What is vasculitis?) on May 19, 2010 from FRANCE Additional patient health information: Female patient , 44 years of age, was diagnosed with sinusitis (What is sinusitis?) and. Monozeclar dosage: .

6728397-8 | Conjunctivitis, Erythema, Lymphadenopathy, Mouth Ulceration, Rash, Rash Macular, Skin Exfoliation
Adverse event was reported on May 10, 2010 by a Male patient taking Monozeclar (View Usage) (Dosage: ) was diagnosed with influenza, neuropathy peripheral and. Location: FRANCE , 62 years of age, After Monozeclar was administered, patient had the following side effects: conjunctivitis, erythema, lymphadenopathy, mouth ulceration, rash (What is rash?), rash macular, skin exfoliation. During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), TOPLEXIL (View Toplexil Review and Toplexil Label ), DERINOX (View Derinox Review and Derinox Label ). Patient was hospitalized.

6699925-6 | Muscular Weakness
on Apr 19, 2010 Female patient from FRANCE , weighting 158.7 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Monozeclar (View Usage). Patient experienced the following unwanted or unexpected effects: muscular weakness. Monozeclar dosage: . During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ).


6404681-2 | Conjunctivitis, Erythema, Lymphadenopathy, Mouth Ulceration, Rash, Rash Macular, Skin Exfoliation
on Oct 07, 2009 Male patient from FRANCE , 62 years of age, was diagnosed with influenza, neuropathy peripheral and was treated with Monozeclar (View Usage). Patient had the following side effects: conjunctivitis, erythema, lymphadenopathy, mouth ulceration, rash (What is rash?), rash macular, skin exfoliation. Monozeclar dosage: . During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), TOPLEXIL (View Toplexil Review and Toplexil Label ), DERINOX (View Derinox Review and Derinox Label ). Patient was hospitalized.

6251822-6 | Conjunctivitis, Lymphadenopathy, Mouth Ulceration
Patient was taking Monozeclar (View Usage). After Monozeclar was administered, patient had the following side effects: conjunctivitis, lymphadenopathy, mouth ulceration on Jun 23, 2009 from FRANCE Additional patient health information: Male patient , 62 years of age, was diagnosed with influenza, neuropathy peripheral and. Monozeclar dosage: . During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), TOPLEXIL (View Toplexil Review and Toplexil Label ), DERINOX (View Derinox Review and Derinox Label ). Patient was hospitalized.

6188390-3 | C-reactive Protein Increased, Candidiasis, Erosive Oesophagitis, Fungal Oesophagitis, Gastritis Erosive, Gastrooesophagitis, Hiccups, Hypokalaemia
Adverse event was reported on May 04, 2009 by a Male patient taking Monozeclar (View Usage) (Dosage: ) was diagnosed with cough, bronchitis (What is bronchitis?) and. Location: FRANCE , weighting 198.4 lb, Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, candidiasis, erosive oesophagitis, fungal oesophagitis, gastritis erosive, gastrooesophagitis, hiccups, hypokalaemia. During the same period patient was treated with PNEUMOREL (View Pneumorel Review and Pneumorel Label ), HELICIDINE (View Helicidine Review and Helicidine Label ), LARGACTIL (View Largactil Review and Largactil Label ), IMOVANE (View Imovane Review and Imovane Label ). Patient was hospitalized.

6173395-9 | C-reactive Protein Increased, Candidiasis, Erosive Oesophagitis, Fungal Oesophagitis, Gastritis Erosive, Gastrooesophagitis, Hiccups, Hypokalaemia
on Apr 20, 2009 Male patient from FRANCE , weighting 198.4 lb, was diagnosed with respiratory tract infection, cough and was treated with Monozeclar (View Usage). Patient had the following side effects: c-reactive protein increased, candidiasis, erosive oesophagitis, fungal oesophagitis, gastritis erosive, gastrooesophagitis, hiccups, hypokalaemia. Monozeclar dosage: . During the same period patient was treated with PNEUMOREL (View Pneumorel Review and Pneumorel Label ), HELICIDINE (View Helicidine Review and Helicidine Label ), LARGACTIL (View Largactil Review and Largactil Label ), IMOVANE (View Imovane Review and Imovane Label ). Patient was hospitalized.

6111872-7 | Face Oedema, Thrombocytopenic Purpura
on Mar 05, 2009 Female patient from FRANCE , weighting 103.6 lb, was diagnosed with cough and was treated with Monozeclar (View Usage). After Monozeclar was administered, patient had the following side effects: face oedema, thrombocytopenic purpura. Monozeclar dosage: . Patient was hospitalized.

6084069-7 | Thrombocytopenic Purpura
Patient was taking Monozeclar (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenic purpura on Feb 11, 2009 from FRANCE Additional patient health information: Female patient , weighting 103.6 lb, was diagnosed with cough and. Monozeclar dosage: . Patient was hospitalized.

6032662-X | Cytolytic Hepatitis, Hepatitis Cholestatic
Adverse event was reported on Jan 02, 2009 by a Female patient taking Monozeclar (View Usage) (Dosage: ) was diagnosed with bronchitis (What is bronchitis?) and. Location: FRANCE , weighting 108.0 lb, Patient had the following side effects: cytolytic hepatitis, hepatitis cholestatic. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CODEINE SUL TAB (View Codeine Sul Tab Review and Codeine Sul Tab Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ). Patient was hospitalized.

6004321-0 | Cytolytic Hepatitis, Hepatitis Cholestatic
on Dec 15, 2008 Female patient from FRANCE , weighting 108.0 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Monozeclar (View Usage). After Monozeclar was administered, patient had the following side effects: cytolytic hepatitis, hepatitis cholestatic. Monozeclar dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ). Patient was hospitalized.

5972672-1 | Cytolytic Hepatitis, Hepatitis Cholestatic
on Dec 01, 2008 Female patient from , weighting 108.0 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Monozeclar (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, hepatitis cholestatic. Monozeclar dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ). Patient was hospitalized.

5968542-5 | Cytolytic Hepatitis, Hepatitis Cholestatic
Patient was taking Monozeclar (View Usage). Patient had the following side effects: cytolytic hepatitis, hepatitis cholestatic on Nov 19, 2008 from Additional patient health information: Female patient , weighting 108.0 lb, was diagnosed with bronchitis (What is bronchitis?) and. Monozeclar dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ). Patient was hospitalized.

5951874-4 | Pemphigus
Adverse event was reported on Nov 13, 2008 by a Male patient taking Monozeclar (View Usage) (Dosage: ) . Location: FRANCE , 66 years of age, After Monozeclar was administered, patient had the following side effects: pemphigus (What is pemphigus?).

5950090-X | Dermatitis Bullous
on Nov 06, 2008 Male patient from FRANCE , 66 years of age, was treated with Monozeclar (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous. Monozeclar dosage: .

5884190-X | Abdominal Distension, Escherichia Sepsis, Fall, Flank Pain, Heart Rate Irregular, Mitral Valve Incompetence, Nephropathy, Rales, Renal Failure Acute
on Sep 11, 2008 Female patient from FRANCE , weighting 187.4 lb, was diagnosed with bronchopneumopathy, atrial fibrillation (What is atrial fibrillation?) and was treated with Monozeclar (View Usage). Patient had the following side effects: abdominal distension, escherichia sepsis, fall (What is fall?), flank pain, heart rate irregular, mitral valve incompetence, nephropathy, rales, renal failure acute. Monozeclar dosage: . During the same period patient was treated with CLAVULANATE POTASSIUM (View Clavulanate Potassium Review and Clavulanate Potassium Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ). Patient was hospitalized.

5754408-2 | Blood Blister, Leukocytosis, Neutrophil Count Abnormal, Purpura, Pyrexia
Patient was taking Monozeclar (View Usage). After Monozeclar was administered, patient had the following side effects: blood blister, leukocytosis, neutrophil count abnormal, purpura, pyrexia on May 26, 2008 from FRANCE Additional patient health information: Male patient , 39 years of age, was diagnosed with gastroenteritis viral, influenza, musculoskeletal stiffness, pyrexia and. Monozeclar dosage: . During the same period patient was treated with IBUROFEN (View Iburofen Review and Iburofen Label ), OXYDE OF LOPERAMIDE (View Oxyde Of Loperamide Review and Oxyde Of Loperamide Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), TETRAZEPAM (View Tetrazepam Review and Tetrazepam Label ), PAROXETINE HCL (20 Mg Daily) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5754403-3 | Abdominal Distension, Escherichia Sepsis, Fall, Flank Pain, Heart Rate Irregular, Mitral Valve Incompetence, Nephropathy, Rales, Renal Failure Acute
Adverse event was reported on May 27, 2008 by a Female patient taking Monozeclar (View Usage) (Dosage: ) was diagnosed with bronchopneumopathy, atrial fibrillation (What is atrial fibrillation?) and. Location: FRANCE , weighting 187.4 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, escherichia sepsis, fall (What is fall?), flank pain, heart rate irregular, mitral valve incompetence, nephropathy, rales, renal failure acute. During the same period patient was treated with CLAVULANATE POTASSIUM (View Clavulanate Potassium Review and Clavulanate Potassium Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ). Patient was hospitalized.

5752614-4 | Myalgia, Rhabdomyolysis
on May 29, 2008 Female patient from FRANCE , weighting 112.4 lb, was diagnosed with nasopharyngitis and was treated with Monozeclar (View Usage). Patient had the following side effects: myalgia, rhabdomyolysis. Monozeclar dosage: . During the same period patient was treated with FENOFIBRATE (100 Mg Daily) (View Fenofibrate Review and Fenofibrate Label ), PREDNISOLONE, NAPHAZOLINE (PREDNISOLONE,NAPHAZOLINE) (View Prednisolone, Naphazoline (prednisolone,naphazoline) Review and Prednisolone, Naphazoline (prednisolone,naphazoline) Label ), TIAPROFENIC ACID (600 Mg Daily) (View Tiaprofenic Acid Review and Tiaprofenic Acid Label ), ACETYLCYSTEINE (600 Mg Daily) (View Acetylcysteine Review and Acetylcysteine Label ), CODEIN/SULFOGAIACOL(CODEINE/SULFOGAIACOL) (View Codein/sulfogaiacol(codeine/sulfogaiacol) Review and Codein/sulfogaiacol(codeine/sulfogaiacol) Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

5749648-2 | Myalgia, Rhabdomyolysis
on May 19, 2008 Female patient from FRANCE , weighting 112.4 lb, was diagnosed with nasopharyngitis and was treated with Monozeclar (View Usage). After Monozeclar was administered, patient had the following side effects: myalgia, rhabdomyolysis. Monozeclar dosage: . During the same period patient was treated with FENOFIBRATE (100 Mg Daily) (View Fenofibrate Review and Fenofibrate Label ), PREDNISOLONE, NAPHAZOLINE (View Prednisolone, Naphazoline Review and Prednisolone, Naphazoline Label ), TIAPROFENIC ACID (600 Mg Daily) (View Tiaprofenic Acid Review and Tiaprofenic Acid Label ), ACETYLCYSTEINE (600 Mg Daily) (View Acetylcysteine Review and Acetylcysteine Label ), CODEIN/SULFOGAIACOL (View Codein/sulfogaiacol Review and Codein/sulfogaiacol Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

5747192-X | Blood Blister, Purpura, Pyrexia
Patient was taking Monozeclar (View Usage). Patient experienced the following unwanted or unexpected effects: blood blister, purpura, pyrexia on May 19, 2008 from FRANCE Additional patient health information: Male patient , 39 years of age, was diagnosed with gastroenteritis viral, influenza, musculoskeletal stiffness, pyrexia and. Monozeclar dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), OXYDE OF LOPERAMIDE (View Oxyde Of Loperamide Review and Oxyde Of Loperamide Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), TETRAZEPAM (View Tetrazepam Review and Tetrazepam Label ), PAROXETINE HCL (20 Mg Daily) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5329392-6 | Ecchymosis, Peripheral Ischaemia
Adverse event was reported on May 10, 2007 by a Female patient taking Monozeclar (View Usage) (Dosage: ) was diagnosed with asthma (What is asthma?), migraine (What is migraine?) and. Location: FRANCE , 47 years of age, Patient had the following side effects: ecchymosis, peripheral ischaemia. During the same period patient was treated with BUDESONIDE/FORMOTEROL (View Budesonide/formoterol Review and Budesonide/formoterol Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ), CTIRIZINE DICHLORHYDRATE (Long-term Treatment) (View Ctirizine Dichlorhydrate Review and Ctirizine Dichlorhydrate Label ), PARACETAMOL (Long-term Treatment) (View Paracetamol Review and Paracetamol Label ), TIOTROPIUM BROMURE (Not Reported) (View Tiotropium Bromure Review and Tiotropium Bromure Label ). Patient was hospitalized.

5269236-4 | Hepatitis Cholestatic, Jaundice, Renal Failure
on Mar 09, 2007 Male patient from FRANCE , 73 years of age, was diagnosed with bronchitis (What is bronchitis?), superinfection and was treated with Monozeclar (View Usage). After Monozeclar was administered, patient had the following side effects: hepatitis cholestatic, jaundice (What is jaundice?), renal failure. Monozeclar dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), RAMIPRIL (1.25 X 2 Per Day) (View Ramipril Review and Ramipril Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), FUROSEMIDE (40x2 Per Day) (View Furosemide Review and Furosemide Label ), REPAGLINIDE (0.5x3 Per Day) (View Repaglinide Review and Repaglinide Label ), FENSPIRIDE (80x3 Per Day) (View Fenspiride Review and Fenspiride Label ). Patient was hospitalized.

5266484-4 | Abdominal Distension, Subileus
on Mar 08, 2007 Male patient from FRANCE , 64 years of age, was treated with Monozeclar (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, subileus. Monozeclar dosage: .

5234154-4 | Asthenia, Pain, Pancreatitis Acute
Patient was taking Monozeclar (View Usage). Patient had the following side effects: asthenia, pain (What is pain?), pancreatitis acute on Jan 29, 2007 from FRANCE Additional patient health information: Female patient , 69 years of age, weighting 154.3 lb, was diagnosed with bronchitis bacterial and. Monozeclar dosage: . Patient was hospitalized.

5220406-0 | Peripheral Ischaemia
Adverse event was reported on Jan 17, 2007 by a Female patient taking Monozeclar (View Usage) (Dosage: ) was diagnosed with asthma (What is asthma?), migraine (What is migraine?) and. Location: FRANCE , 47 years of age, After Monozeclar was administered, patient had the following side effects: peripheral ischaemia. During the same period patient was treated with BUDESONIDE/FORMOTEROL (View Budesonide/formoterol Review and Budesonide/formoterol Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ), CTIRIZINE DICHLORHYDRATE (Long-term Treatment) (View Ctirizine Dichlorhydrate Review and Ctirizine Dichlorhydrate Label ), PARACETAMOL (Long-term Treatment) (View Paracetamol Review and Paracetamol Label ), TIOTROPIUM BROMURE (Not Reported) (View Tiotropium Bromure Review and Tiotropium Bromure Label ). Patient was hospitalized.

5211656-8 | Asthenia, Pain, Pancreatitis Acute
on Jan 08, 2007 Female patient from FRANCE , 69 years of age, weighting 154.3 lb, was diagnosed with bronchitis bacterial and was treated with Monozeclar (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, pain (What is pain?), pancreatitis acute. Monozeclar dosage: . Patient was hospitalized.

5202429-0 | Gait Disturbance
on Jan 02, 2007 Male patient from FRANCE , 80 years of age, was diagnosed with nasopharyngitis, bronchitis (What is bronchitis?) and was treated with Monozeclar (View Usage). Patient had the following side effects: gait disturbance. Monozeclar dosage: .

5130942-3 | Cyst, Haemangioma
Patient was taking Monozeclar (View Usage). After Monozeclar was administered, patient had the following side effects: cyst, haemangioma on Sep 27, 2006 from FRANCE Additional patient health information: Female patient , weighting 7.76 lb, . Monozeclar dosage: .

5122178-7 | Cyst, Haemangioma
Adverse event was reported on Sep 27, 2006 by a Female patient taking Monozeclar (View Usage) (Dosage: ) . Location: FRANCE , weighting 7.76 lb, Patient experienced the following unwanted or unexpected effects: cyst, haemangioma.

5100152-4 | Eczema, Folliculitis, Lymphadenopathy, Toxic Skin Eruption
on Aug 29, 2006 Female patient from FRANCE , 38 years of age, weighting 110.2 lb, was diagnosed with bronchopneumonia and was treated with Monozeclar (View Usage). Patient had the following side effects: eczema (What is eczema?), folliculitis, lymphadenopathy, toxic skin eruption. Monozeclar dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), AMBROXOL (View Ambroxol Review and Ambroxol Label ). Patient was hospitalized.

5083783-X | Agranulocytosis, Blood Glucose Increased, C-reactive Protein Increased, Febrile Neutropenia, Tonsillar Ulcer, Tonsillitis, White Blood Cell Count Increased
on Aug 09, 2006 Male patient from FRANCE , 68 years of age, was treated with Monozeclar (View Usage). After Monozeclar was administered, patient had the following side effects: agranulocytosis, blood glucose increased, c-reactive protein increased, febrile neutropenia, tonsillar ulcer, tonsillitis, white blood cell count increased. Monozeclar dosage: . During the same period patient was treated with SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), METFORMIN (View Metformin Review and Metformin Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.